QA: Bioxytran INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2013_Bioxytran_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 299,375
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 129,063
3 remainder_Assets 0
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 74,371
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 2,602,615
11 remainder_Revenues 312,903
12 remainder_NetIncome -3,546
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 428,438
1 Liabilities 74,371
2 Expenses 2,602,615
3 Revenues 312,903
4 StockholdersEquity 354,067
5 NetIncome -2,293,258
6 ComprehensiveNetIncome -2,293,258
7 BaseVar 1,710,936
8 EconomicCapitalRatiobeforeLimitedLiability -6.05
9 EconomicCapitalRatio 0.0753

Edgar->Model Mapping

Feature Distribution